WASHINGTON and SEOUL, South Korea, Sept. 13, 2012
WASHINGTON and SEOUL, South Korea, Sept. 13, 2012 /PRNewswire/ -- Partners of Sughrue Mion PLLC , a global intellectual property law firm, recently addressed the impact of new U.S. patent legislation on international markets at the 2012 BIO KOREA Health for Humanity Conference held in Seoul, Korea on September 12-14.
The 7th Annual BIO KOREA Conference focused on a diverse range of applications and areas such as medical care, food, agriculture, energy, chemicals, and the environment. Several Sughrue Mion partners led the track on IP Legal Matters, discussing the impact of the latest patent legislation overhaul on the biologics and pharmaceutical industries.
Presentations included "The Challenges of Inter Partes Review for Pharma and Bio Companies" by Mike Dzwonczyk; "Successful IP Strategies for Biotech Platforms Technologies" by Karen Dow; "Post Grant Review Under the America Invents Act (AIA)" by Chid Iyer; and "Challenges on Patent Protection of Diagnostic Method and Personalized Treatment Methods in the U.S." by Sunhee Lee.
The three-day conference hosted approximately 4,500 representatives from the bio industry, research institutes, and academic organizations, as well as interested individuals from Korea and throughout the world. Established in 2006, the annual BIO KOREA conference is now the most influential and best-known event of its kind in Asia. The conference provides an opportunity for domestic and foreign investors to meet fast-growing Korean bio companies and leading Korean research institutions.
Sughrue Mion's participation in this year's BIO KOREA Health for Humanity Conference is one of many examples of the firm's commitment to providing education and counsel on diverse intellectual property topics.
In addition to several events in Europe and Asia this fall, Sughrue Mion will host the inaugural Robert Shaw International Intellectual Property Symposium on International IP Practice and the America Invents Act.
The event will occur at the University of New Hampshire on April 25, 2013.
About Sughrue Mion, PLLC
Sughrue Mion is the leading global intellectual property firm, helping thousands of companies from around the world navigate the complexities of patent and trademark law since 1957. Sughrue's practice is focused solely on intellectual property law, and the firm has helped its clients secure more patents than any other U.S. patent firm. Many of Sughrue's attorneys have worked as Examiners in the U.S. Patent and Trademark Office (USPTO), and more than 95 percent of the firm's attorneys are licensed to practice before the USPTO. Sughrue brings unmatched experience in patent interference proceedings and Post Grant Review, including ex parte and inter partes reexamination proceedings. This expertise provides the firm's clients with a clear advantage navigating the new America Invents Act (AIA) regulations. In addition to their legal expertise, Sughrue's attorneys have technical and scientific backgrounds ranging from biosimilars to nanotechnology, which allow for a true understanding of its clients' businesses and business challenges. For more information, please visit www.sughrue.com.
SOURCE Sughrue Mion PLLCPR Newswire
Last updated on: 13/09/2012
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.